Gates Foundation invests $40 mln in UK immunotherapy company
September 18, 2017 at 02:51 AM EDT
LONDON, Sept 18 (Reuters) - The Bill & Melinda Gates Foundation is to invest up to $40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases.
